MedTrace Logo

Hyaluronic Acid Versus Red Injectable Platelet Rich Fibrin in Treatment of Periodontitis

NCT05768243 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-03-14

No results posted yet for this study

Summary

the aim of this clinical trial is to compare the efficacy of hyaluronic acid (HA) used as an adjunctive to scaling and root planing (SRP) and red injectable platelet rich-fibrin (i-PRF) in the non-surgical treatment of stage III periodontitis. The main question it aims to answer is: is there a difference between HA and red i-prf when used as an adjunct to SRP in terms of efficacy?

Participants who are eligible will be assigned to one of the treatment groups:

* Group 1= receives HA+ SRP
* Group 2= receives red i-prf + SRP
* Group 3= receives only SRP

Researchers will compare Groups 1,2 and 3 to see if there's a difference in the periodontal parameters measured.

Conditions

  • Periodontitis Chronic Generalized Severe

Interventions

DRUG

Hyaluronic acid

hyaluronic acid is used as an adjunctive treatment to scaling and root planing

PROCEDURE

red injectable platelet rich fibrin (i-prf)

injecting red i-prf into the pocket after scaling and root planing

Sponsors & Collaborators

  • Beirut Arab University

    lead OTHER

Principal Investigators

  • Nayer Aboelsaad, PhD · Professor and Chairman of Periodontology department - BeirutArabU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-07-24
Completion
2022-09-17

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768243 on ClinicalTrials.gov